Why you should participate

BioKorea is Asia’s leading global bio-health convention, bringing together innovators, industry leaders, and investors from around the world. For nearly two decades, it has served as a premier platform for showcasing cutting-edge biotechnology, forging international partnerships, and accelerating commercialisation opportunities. BioKorea 2026 will mark the 12th year of Team Australia’s participation, highlighting Australia’s world-class R&D capabilities and driving new Australia-Korea partnerships across the biotech and life science sectors.

Australian clinical trials service providers, pharma manufacturers, and digital health companies will have the opportunity to raise their profile on an international platform, unlock new export markets, increase export sales, and build partnerships and connections.    

Companies and research institutes across the following segments are encouraged to apply:

Austrade’s business program will encompass tailored business meetings, market briefings, and networking events in the lead up to, and during BioKorea. Austrade will work with all the Australian state and territory governments to support outstanding Australian biotech and health businesses in their export growth.